Navigation Links
ADHD Drug Delays Puberty in Male Monkeys, Study Finds
Date:9/19/2011

By Maureen Salamon
HealthDay Reporter

MONDAY, Sept. 19 (HealthDay News) -- The widely used attention-deficit/hyperactivity disorder (ADHD) medication methylphenidate -- best known as Ritalin -- appears to be tied to delayed puberty in male monkeys.

But, researchers cautioned that the finding needs to be replicated before parents should concern themselves about similar effects in boys.

Male primates given methylphenidate over a 40-month span experienced "impaired testicular descent" and smaller-sized testicles, as well as lower testosterone levels, all of which resolved over the course of the study.

"To our knowledge, it's the first observation in primates to suggest an alteration in testicular function," said study author Dr. Donald Mattison, a medical officer at the National Institute of Child Health and Human Development, part of the U.S. National Institutes of Health.

"We believe they're interesting observations, but substantially more work needs to be done . . . to make sure they're repeatable," Mattison said. "It's really too early to say there are clinical implications."

The study is published in this week's online issue of the Proceedings of the National Academy of Sciences.

The most commonly diagnosed behavioral disorder in childhood, ADHD affects between 3 percent and 5 percent of school-age kids, mostly boys. Ritalin and other forms of methylphenidate have long been the most widely used drugs to treat ADHD, which involves issues of inattentiveness, overactivity and impulsivity. Other brand name versions of methylphenidate include Concerta, Metadate and Methylin.

According to Mattison, the young rhesus monkeys in the study were given either a low dose or high dose of methylphenidate, with the low dose designed to match typical blood levels of the drug observed in human ADHD patients. The high dose was intended to produce blood levels five to 10 times higher than used in people, he said.

"Testicular descent," part of the male maturation process, was postponed "significantly" in monkeys given the high (but not lower) dose of methylphenidate, the study found, while lowered testicular volume and blood testosterone levels were noted in monkeys given either the low- or high-dose regimens.

The effects on testicular function were a complete surprise, Mattison noted, since the study was designed to evaluate other types of potential toxicity from methylphenidate, including possible DNA damage.

"I think the results are more to keep in mind, and we haven't made any recommendations for clinical practice," he said. "But we encourage clinicians and scientists to think about puberty as a potential endpoint that might be affected. So we're pretty cautious at this point."

Dr. Spyros Mezitis, an endocrinologist at Lenox Hill Hospital in New York, said hormonal systems are very similar in primates and humans, but he has not observed any testosterone-related symptoms in patients taking methylphenidate.

"This is a standalone study . . . so we need more studies to understand what's happening here," Mezitis said. "In the endocrine community, when it comes to the use of Ritalin, we're not really considering testosterone levels, but maybe we should now."

A spokesperson for Novartis Pharmaceuticals Corp., which manufactures Ritalin, said it was important to note that the study was conducted in monkeys and showed the impact of methylphenidate on puberty was not permanent.

"We have specifically examined our post-marketing data for reports of delayed sexual maturation," spokesman Michael Billings said. "From the data available, no association between the use of our methylphenidate products and delays in sexual maturation has been been established."

More information

There's more on ADHD at the U.S. National Library of Medicine.

SOURCES: Donald Mattison, M.D., medical officer, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Md.; Dr. Spyros Mezitis, endocrinologist, Lenox Hill Hospital, New York City; Michael Billings, spokesperson, Novartis Pharmaceuticals Corp., East Hanover, N.J.; Sept. 19-23, 2011, Proceedings of the National Academy of Sciences


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. One-Third of Severe Heart Attack Patients Have Treatment Delays
2. Many Pediatricians Arent Testing Tots for Developmental Delays
3. Hospital Delays Tied to Racial Divide in Heart Attack Care
4. Delays in Hospital Transfers for Heart Attack Patients May Raise Death Risk
5. Language Delays Seen in Kids in Institutions Beyond Age 2
6. Antifungal drug delays need for chemo in advanced prostate cancer
7. FDA Panel Delays Action on Dyes Used in Foods
8. Outcomes improved by longer delays between heart attacks and elective surgeries
9. Blood Pressure Drug Delays Kidney Disease in Diabetics
10. Heart Patients With Depression Often Find ER Delays
11. Delivery Even a Bit Early May Mean Developmental Delays
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
ADHD Drug Delays Puberty in Male Monkeys, Study Finds
(Date:6/26/2016)... ... June 26, 2016 , ... Many ... been diagnosed with endometriosis. These women need a treatment plan to not only ... approach that can help for preservation of fertility and ultimately achieving a pregnancy. ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... of its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. ... James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
(Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the addition of ... Forecast to 2022" report to their offering. ... date financial data derived from varied research sources to present ... impact on the market during the next five years, including ... sub markets, regional and country level analysis. The report provides ...
(Date:6/23/2016)... , June 23, 2016 Bracket , a ... its next generation clinical outcomes platform, Bracket eCOA (SM) ... on June 26 – 30, 2016 in Philadelphia ... electronic Clinical Outcome Assessment product of its kind to fully ... Bracket eCOA 6.0 is a flexible platform for ...
(Date:6/23/2016)... NORTHBROOK, Ill. and BOGOTA, Colombia , June 23, 2016  Astellas today announced the ... joins Astellas Farma Brasil as the company,s second affiliate in Latin America . ... ... appointed General Manager of Astellas Farma Colombia ... ...
Breaking Medicine Technology: